Health

Update on the Safety of Andexxa by AstraZeneca: FDA Safety Communication

DailyTrendDailyTrend
Dec 22, 2025 - 15:00
 0  2
Update on the Safety of Andexxa by AstraZeneca: FDA Safety Communication
Since approval, the FDA has received postmarketing safety data on thromboembolic events, including serious and fatal outcomes, in patients treated with Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo). Based on available data, the serious risks including the increase in thromboembolic
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

Should Drug Companies Be Advertising to Consumers?

Should Drug Companies Be Advertising to Consumers?

DailyTrend Feb 17, 2026  0  1

RFK Jr. Allies Target States to Overturn Vaccine Mandates for Schools

RFK Jr. Allies Target States to Overturn Vaccine Mandat...

DailyTrend Feb 17, 2026  0  1

Measles Outbreak Hits Ave Maria University in Florida

Measles Outbreak Hits Ave Maria University in Florida

DailyTrend Feb 17, 2026  0  1

New Method Can Find Hidden Eggs to Aid in Fertility Treatment

New Method Can Find Hidden Eggs to Aid in Fertility Tre...

DailyTrend Feb 12, 2026  0  0

Senate Questions Health Care Firm for Profiting Off Program Meant for Poor

Senate Questions Health Care Firm for Profiting Off Pro...

DailyTrend Feb 12, 2026  0  1

4 Months Trapped in a Hospital for an Obsolete Way of Treating Their Disease

4 Months Trapped in a Hospital for an Obsolete Way of T...

DailyTrend Feb 12, 2026  0  0